Ancora Advisors LLC Acquires New Shares in Agilent Technologies, Inc. $A

Key Points

• Ancora Advisors acquired 24,255 Agilent shares during the second quarter, establishing a new position valued at approximately $3.22 million. Several other institutional investors also recently initiated stakes.
• Agilent exceeded third-quarter expectations, reporting revenue of $1.88 billion and adjusted EPS of $1.62, while operating profit and cash flow rose substantially year over year.
• Management raised fiscal 2026 adjusted EPS guidance to $6.18–$6.21 and revenue guidance to about $7.5 billion. Analysts maintain a “Moderate Buy” consensus with a $160.24 target, though the stock’s valuation above 31 times earnings and proximity to its 12-month high present risks.

Ancora Advisors LLC acquired a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 24,255 shares of the medical research company's stock, valued at approximately $3,222,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Core Wealth Advisors LLC purchased a new position in shares of Agilent Technologies during the 4th quarter worth approximately $26,000. SHP Wealth Management acquired a new position in Agilent Technologies during the fourth quarter worth $26,000. Navalign LLC purchased a new position in shares of Agilent Technologies during the fourth quarter worth $27,000. Cedar Mountain Advisors LLC purchased a new position in shares of Agilent Technologies during the first quarter worth $27,000. Finally, MV Capital Management Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at $28,000.

Key Headlines Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Analysts Set New Price Targets

A number of brokerages recently commented on A. HSBC lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a report on Wednesday, June 3rd. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They set an "outperform" rating and a $155.00 price target on the stock. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Piper Sandler began coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 price objective for the company. Finally, Wells Fargo & Company cut their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $160.24.

Agilent Technologies Stock Performance

NYSE:A opened at $155.16 on Thursday. The firm has a market capitalization of $43.82 billion, a PE ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. The business's fifty day moving average price is $139.16 and its 200 day moving average price is $126.65. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.51.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies's revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source